A Methylation Panel for Bladder Cancer
No involved investigator sites defined.
Participate in a prevalidation study for methylation based detection of bladder cancer. In addition, a panel of three markers identified will be evaluated for their ability to a) identify bladder cancer patients from those with benign urologic disease; b) identify patients with superficial (papillary) cancers from those with high grade invasive cancers
There are currently no biomarkers annotated for this protocol.
No datasets are currently associated with this protocol.